Clinical trial
Prognostic and Predictive Biomarkers in Ovarian Cancers
NCT03010124 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic and Predictive Biomarkers in Ovarian Cancers
- Lead sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 26, 2016
- Completion date
- September 30, 2032
- Enrollment
- 350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer